DR. JORN ROBIJN financials
A multi-period view of the public annual-account figures reported for DR. JORN ROBIJN, with comparable measures and links to available source documents.
Company overviewRegistry number
0827041596
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for DR. JORN ROBIJN
2025 versus 2024
- Operating line
- €380,164
- EBITDA
- €376,055
- Total assets
- €1,437,483
- Equity
- €1,110,320
+6.7%
+6.8%
+14%
+25.5%
EBITDA margin +98.9% · Equity ratio +77.2%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €380,164 | €376,055 | €1,437,483 | €1,110,320 | - |
| 202431 Dec 2024 | €356,322 | €352,159 | €1,261,199 | €884,370 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.